Detalhe da pesquisa
1.
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression.
Hum Psychopharmacol;
37(4): e2836, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35179810
2.
Impact of Delirium and Its Motor Subtypes on Stroke Outcomes.
Stroke;
52(4): 1322-1329, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33719516
3.
Intravenous arketamine for treatment-resistant depression: open-label pilot study.
Eur Arch Psychiatry Clin Neurosci;
271(3): 577-582, 2021 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32078034
4.
MicroRNAs as Diagnostic Biomarkers and Predictors of Antidepressant Response in Major Depressive Disorder: A Systematic Review.
Cureus;
16(3): e56910, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38665721
5.
Arketamine for bipolar depression: Open-label, dose-escalation, pilot study.
J Psychiatr Res;
164: 229-234, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37385001
6.
Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial.
Trends Psychiatry Psychother;
45: e20210298, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34904800
7.
Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine and esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial.
Trends Psychiatry Psychother;
2023 Sep 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37717263
8.
Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study.
J Affect Disord;
330: 7-15, 2023 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36871913
9.
Effects of GRIN2B , GRIA1 , and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a Randomized Clinical Trial.
Clin Neuropharmacol;
45(6): 151-156, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36093918
10.
Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial.
J Psychiatr Res;
138: 576-583, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33991996
11.
Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study.
J Affect Disord;
264: 527-534, 2020 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31786030
12.
Discussing clozapine adverse effects and monitoring strategies: a focus on ethnic diversity.
Braz J Psychiatry;
45(5): 461-462, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37792800
13.
Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial
Trends psychiatry psychother. (Impr.);
45: e20210298, 2023. tab, graf
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1424715
14.
Ketamine and Esketamine augmentation for suicidal ideation: A randomized, double-blinded clinical trial.
Gen Hosp Psychiatry;
68: 97-99, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33376001
15.
Discussing clozapine adverse effects and monitoring strategies: a focus on ethnic diversity
Braz. J. Psychiatry (São Paulo, 1999, Impr.);
45(5): 461-462, Sept.-Oct. 2023.
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1528005